Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs.
about
Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagusPredicting plasma concentrations of bisphenol A in children younger than 2 years of age after typical feeding schedules, using a physiologically based toxicokinetic modelUDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patientsUpdate on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy.UDP-glucuronosyltransferase 1A10: activity against the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and a potential role for a novel UGT1A10 promoter deletion polymorphism in cancer susceptibility.Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT).Characterization of UDP-glucuronosyltransferase 2A1 (UGT2A1) variants and their potential role in tobacco carcinogenesis.Uridine 5'-diphospho-glucuronosyltransferase genetic polymorphisms and response to cancer chemotherapy.S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen.A human minor histocompatibility antigen resulting from differential expression due to a gene deletionCopy Number Variation of UGT 2B Genes in Indian Families Using Whole Genome Scans.Implication of Human UGT2B7, 2B15, and 2B17 in 19-Norandrosterone Metabolism.Genetic variations in UGT1A1 and UGT2B7 and endometrial cancer riskEffects of menthol on tobacco smoke exposure, nicotine dependence, and NNAL glucuronidation.Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.Aldosterone glucuronidation by human liver and kidney microsomes and recombinant UDP-glucuronosyltransferases: inhibition by NSAIDs.Association between UGT2B7 gene polymorphisms and fentanyl sensitivity in patients undergoing painful orthognathic surgery.Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation.Early post-traumatic seizures are associated with valproic acid plasma concentrations and UGT1A6/CYP2C9 genetic polymorphisms in patients with severe traumatic brain injury.Involvement of CYP2C9 and UGT2B7 in the metabolism of zaltoprofen, a nonsteroidal anti-inflammatory drug, and its lack of clinically significant CYP inhibition potential.Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene.Effect of antiepileptic drug comedication on lamotrigine concentrations.
P2860
Q24531398-93B5A8A5-E491-4F5F-B969-525978B6A8ADQ24647832-1721E14E-D6D5-47AB-8662-9BB7E7A4E5C1Q24806179-3A1E9AC8-D506-4761-BC48-8EB237D8F013Q33664128-1BE8A949-CA04-40AF-8611-7FEB13611AD1Q33714575-0641E4DD-3DAB-4AFB-BAC8-08502D0A4769Q34325249-51C8930E-667D-45E9-BA1A-07F0862244F5Q34482453-3F81A889-F952-437C-977B-83D61D21A039Q35008045-C2EC3C32-1464-4AFA-AEB9-1D14A1D11C46Q35826926-C6126937-5959-4ED9-8012-3394E02E551DQ36370375-C2FC2B29-FEAA-4AA0-BA73-F87BF664CE31Q36764660-C4E5FC79-4CA9-42A9-A1D5-2935DF0D13D0Q36955916-59399C5F-DF8C-4F95-9BBC-6E6433F98C62Q37155153-E9F3A6E2-30B2-4D98-B690-D12DD738B637Q37178887-48A4D431-2985-41A7-831C-1785F07C250AQ37378223-1619CBB5-82AF-47DD-8661-30537586CAA7Q37397801-7FB51BAA-CFB1-4131-859D-C5D2863EF95DQ41087224-F62BBDB6-4CB1-43C1-B221-577C73A1FE9BQ41437632-B1EE11FD-E86E-4CFE-9A3E-DDFB320CC97FQ41542027-957C4D04-2729-4749-A94C-C6EE877D3D85Q41936171-180DD840-B9ED-4159-BBC0-73089C656839Q42661955-AE3609AF-D3CA-45D3-A6C4-734B4B1214DCQ54944130-363BA44C-14D2-45F4-9B2F-0F39A11BF16F
P2860
Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Complementary deoxyribonucleic ...... boxylic acid-containing drugs.
@ast
Complementary deoxyribonucleic ...... boxylic acid-containing drugs.
@en
type
label
Complementary deoxyribonucleic ...... boxylic acid-containing drugs.
@ast
Complementary deoxyribonucleic ...... boxylic acid-containing drugs.
@en
prefLabel
Complementary deoxyribonucleic ...... boxylic acid-containing drugs.
@ast
Complementary deoxyribonucleic ...... boxylic acid-containing drugs.
@en
P2093
P1476
Complementary deoxyribonucleic ...... rboxylic acid-containing drugs
@en
P2093
Lillywhite KJ
Mackenzie PI
P304
P407
P577
1993-01-01T00:00:00Z